<DOC>
	<DOCNO>NCT02909335</DOCNO>
	<brief_summary>Tacrolimus calcineurin inhibitor . This immunosuppression reference patient undergo first liver transplant . This treatment prevent graft rejection , cause side effect include kidney failure ( 25 % first year ) . Everolimus immunosuppressive effectively prevent acute rejection heart kidney transplant recipient . It preserve renal function start soon transplant , i.e . severe dysfunction instal .</brief_summary>
	<brief_title>De Novo Everolimus Versus Tacrolimus Combination With Mofetil Mycophenolate Low Dose Corticosteroids Reduce Tacrolimus Induced Nephrotoxicity Liver Transplantation : Prospective , Multicentric , Randomised Study</brief_title>
	<detailed_description>In liver transplant , early interruption calcineurin inhibitor quick relay everolimus monotherapy preserve renal function associate low acute rejection rate . We wish ass whether introduction de novo immunosuppression everolimus protection basiliximab induction , mycophenolate mofetil low dos corticosteroid , reduces nephrotoxicity immunosuppressive therapy liver transplant patient , compare standard protocol tacrolimus associate mycophenolate mofetil low dose corticosteroid .</detailed_description>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Pretransplantation Adults ( â‰¥18 year ) , male female , Patients due receive first liver transplant full reduce graft take donor braindead beat heart relate living donor , Patients give free inform write consent . Posttransplantation Inclusion criterion : Patients meet follow criterion include : Receiving basiliximab ( Simulect ) Whose immunosuppression regimen day 5 could immediately consist either tacrolimus everolimus , combination mycophenolate mofetil low dose corticosteroid With hepatic artery permeable echo Doppler 4 day transplant . History immunosuppressive therapy , Known hypersensitivity treatment macrolides , HIV infection Autoimmune hepatitis , Primary sclerosing cholangitis , Programming realization combine transplant , Pregnancy lack effective contraception , Breastfeeding . Incompatibility donor , Thrombosis hepatic artery D0 D4 , Nonprimary graft function lead reregistration wait list .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>